ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO770

Mortality Risk According to eGFR and Proteinuria in Persons Older Than 65 Years: Results From a Nationwide Study in Iceland

Session Information

Category: Geriatric Nephrology

  • 1200 Geriatric Nephrology


  • Jonsson, Arnar Jan, Landspitali–The National University Hospital of Iceland, Reykjavik, Iceland
  • Lund, Sigrún Helga, deCODE Genetics Inc, Reykjavik, Capital, Iceland
  • Eriksen, Bjorn Odvar, University Hospital of North Norway, Tromso, Norway
  • Palsson, Runolfur, Landspitali–The National University Hospital of Iceland, Reykjavik, Iceland
  • Indridason, Olafur S., Landspitali–The National University Hospital of Iceland, Reykjavik, Iceland

Kidney function is known to decline with age, nevertheless, a uniform definition of glomerular filtration rate (GFR) has been applied to define chronic kidney disease irrespective of age. This has mostly been based on cross-sectional studies using single assessment of estimated glomerular filtration rate (eGFR), that have indicated worse outcome at eGFR <60 mL/min/1.73 m2. The aim of this study was to examine the risk of all-cause mortality according to eGFR and proteinuria in persons aged >65 years in the general population.


We obtained all serum creatinine (SCr) and urine protein measurements from all clinical laboratories in Iceland in the years 2008-2016. Clinical data were obtained from nationwide electronic medical records. eGFR was calculated using the CKD-EPI equation and classified into categories; 0-29, 30-44, 45-59, 60-74, 75-89, 90-104 and >104 mL/min/1.73 m2 eGFR category and proteinuria had to be persistent for >3 months. A multiple imputation method was used to account for missing urine protein measurement data. A joint model using repeated measurements was used to assess mortality and simultaneously account for decline in eGFR over time, adjusting for age as a continuous variable, sex and multiple comorbid conditions.


We obtained 782,995 SCr values for 37,937 individuals aged over 65 years, of whom 23,344 (62%) had information on proteinuria. The median age was 75 (range, 66-106) years and 46% were men. Adjusted hazard ratios for all-cause mortality are demonstrated in the table.


Among elderly individuals, eGFR >104 mL/min/1.73 m2 carries a high mortality risk, whereas eGFR of 45-74 without proteinuria is associated with the lowest mortality.

Adjusted hazard ratio (95% CI) for death according to eGFR and proteinuria
eGFR (mL/min/1.73 m2)No proteinuriaProteinuria
>1044.28 (2.88-6.36)4.47 (2.15-9.31)
90-1041.55 (1.40-1.73)2.23 (1.92-2.60)
75-891.08 (1.02-1.15)1.62 (1.50-1.75)
60-74Reference1.42 (1.32-1.54)
45-591.05 (0.99-1.12)1.46 (1.35-1.57)
30-441.33 (1.23-1.44)1.41 (1.28-1.55)
0-291.97 (1.75-2.21)2.09 (1.84-2.37)


  • Government Support – Non-U.S.